Halford, W. P., & Schaffer, P. A. (2000). Optimized Viral Dose and Transient Immunosuppression Enable Herpes Simplex Virus ICP0-Null Mutants To Establish Wild-Type Levels of Latency In Vivo. American Society for Microbiology.
Chicago-tyylinen lähdeviittausHalford, William P., ja Priscilla A. Schaffer. Optimized Viral Dose and Transient Immunosuppression Enable Herpes Simplex Virus ICP0-Null Mutants To Establish Wild-Type Levels of Latency In Vivo. American Society for Microbiology, 2000.
MLA-viiteHalford, William P., ja Priscilla A. Schaffer. Optimized Viral Dose and Transient Immunosuppression Enable Herpes Simplex Virus ICP0-Null Mutants To Establish Wild-Type Levels of Latency In Vivo. American Society for Microbiology, 2000.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.